NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 140 filers reported holding NEKTAR THERAPEUTICS in Q1 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,164,000 | +266.0% | 49,600 | +142.0% | 0.04% | -61.9% |
| Q4 2014 | $318,000 | -54.9% | 20,500 | -64.9% | 0.10% | -78.3% |
| Q3 2014 | $705,000 | +235.7% | 58,400 | +256.1% | 0.48% | +393.9% |
| Q2 2014 | $210,000 | -64.9% | 16,400 | -66.8% | 0.10% | -44.0% |
| Q1 2014 | $599,000 | – | 49,400 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |